DE / EN
Pharma Trend is the independent benchmark study on innovation and sustainability. Each year physicians, pharmacists and patients rate the most innovative companies and products, forming the basis for the awards “The Golden Tablet”® and “Most Innovative Product”®.
Per specialty, 100 physicians or pharmacists, or 600 patients are surveyed. Winners are determined through open questions, with no companies or products suggested.
The study has been conducted on behalf of the magazine PharmaBarometer since 2000 in the Rx category, since 2018 also in OTC and Orphan Drugs, since 2019 in Specialty Care, and since 2021 in Diagnostics and Digital Health. Representativeness is verified by the international market-research company Harris Interactive. The standardised questionnaire is protected; clients exert no influence on the results.
Awarded for innovation and sustainability since 2000, determined through open questions.
For the most innovative and sustainable company per specialty.
For the medicine with the highest benefit from the users' perspective.
Over €240,000 for charitable, sustainable engagement.